Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability

International Immunology

Volumn 11, Issue 9, 1999, Pages 1363-1370

  Prohászka, Zoltán ^a,b,h   Duba, Jenõ ^c   Lakos, Gabriella ^d   Kiss, Emese ^d   Varga, Lilian ^e   Jánoskuti, Lívia ^a   Császár, Albert ^a,b   Karádi, István ^a,b   Nagy, Kálmán ^f   Singh, M ^g   Romics, László ^a,b   Füst, George ^a,b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c National Institute of Cardiology Budapest   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e National Institute of Haematology and Immunology Budapest   (Hungary)

^f Borsod County Teaching Hospital   (Hungary)

^g HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^h NONE   (Hungary)

Author keywords

Anti hsp60 antibodies; Anti hsp65 antibodies; Atherosclerosis; Classical pathway; Complement activation; Human heat shock protein 60; Mycobacterial heat shock protein 65

Indexed keywords

HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; IMMUNOGLOBULIN G ANTIBODY; PROTEIN ANTIBODY; RECOMBINANT PROTEIN;

ADULT; AGAMMAGLOBULINEMIA; AGED; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; CELL DAMAGE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CROSS REACTION; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGAMMAGLOBULINEMIA; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHAPERONIN 60; CHAPERONINS; CHILD, PRESCHOOL; COMPLEMENT PATHWAY, CLASSICAL; CORONARY DISEASE; CROSS REACTIONS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 0344980826     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.9.1363     Document Type: Article

References (26)

1. Torzewski, J., Bowyer, D. E., Waltenberger, J. and Fitzsimmons, C. 1997. Processes in atherogenesis: complement activation. Atherosclerosis 132:131.
2. Seifert, P. S., Hugo, F., Tranum-Jensen, J., Zähringer, U., Muhly, M. and Bhakdi, S. 1990. Isolation and characterization of a complement activating lipid extracted from human atherosclerotic lesions. J. Exp. Med. 172:547.
3. Torzewski, J., Oldroyd, R., Lachmann, P. J., Fitzsimmons, C. J., Proudfoot, D. and Bowyer, D. E. 1996. Complement induced release of monocyte chemotactic protein from human smooth muscle cells: a possible initiating event in atherosclerotic lesion formation. Arteriscler. Thromb. Vasc. Biol. 16:673.
4. Bhakdi, S., Dorweiler, B., Kirchmann, R., Torzewski, J., Weise, E., Tranum-Jensen, J., Walev, L. and Wieland, E. 1995. On the pathogenesis of atherosclerosis. Enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J. Exp. Med. 182:1959.
5. Haviland, D. L., McCoy, R. L., Whitehead, W. T., Akama, H., Molmenti, E. P., Brown, A., Haviland, J. C., Parks, W. C., Perlmutter, D. H. and Wetzel, R. A. 1995. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and the lung. J. Immunol. 154:1861.
6. Wick, G., Schett, G., Amberger, A., Kleindienst, R. and Xu, Q. 1995. Is atherosclerosis an immunologically mediated disease? Immunol. Today 16:27
7. Amberger, A., Maczek, C., Jurgens, G., Michaelis, D., Schett, G., Trieb, K., Eberl, T., Jindal, S., Xu, Q. and Wick, G. 1997. Coexpression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones 2: 94
8. Nityanand, S., Bergmark, C., de Faire, U., Swedenborg, J., Holm, G. and Lefvert, A. K. 1995 Antibodies against endothelial cells and cardiolipin in young patients with periferial atherosclerotic disease. J. Intern. Med. 238:437
9. Kilgore, K. S., Friedrichs, G. S., Homeister, J. W. and Lucchesi, B. R. 1994. The complement system in myocardial ischemia/ reperfusion injury. Cardiovasc. Res. 28:437.
10. Weiser, M. R., Williams, J. P., Moore, F. D., Jr, Kobzik, L., Ma, M., Hechtman, H. B. and Carroll, M. 1996. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183:2343.
11. Collard, C. D., Väkevä, A., Büküsoglu, C., Zünd, G., Sperati, J. C., Colgan, S. P. and Stahl, G. L. 1997. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 96:326
12. Hopplicher, F., Lechleitner, M., Traweger, C., Schett, G., Dzien, A., Sturm, W. and Xu, Q. 1996. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 126:333.
13. Prohászka, Z., Hidvégi, T., Ujhelyi, E., Stoiber, H., Dierich, M. P., Süsal, C. and Fust, G. 1995. Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1. Immunology 85:184.
14. Prohászka, Z., Német, K., Csermely, P., Hudecz, F., Mezõ, G. and Fust, G. 1997. Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1. Mol. Immunol. 34:809.
15. Prohászka, Z., Bánhegyi, D., Ujhelyi, E., Karádi, I. and Füst, G. 1998. Antibodies against 60kD heat-shock proteins in human immunodeficiency virus infection. Ann. NY Acad. Sci. 851:94
16. Birnie, D. H., Holme, E. R., McKay, I. C., Hood, S., McColl, K. E. L. and Hillis, W. S. 1998. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J. 19:387.
17. Schett, G., Xu, Q., Amberger, A., van der Zee, R., Recheis, H., Willeit, J. and Wick, G. 1995. Autoantibodies against heat-shock protein 60 mediate endothelial cytotoxicity. J. Clin. Invest. 96:2569.
18. Schett, G., Metzler, B., Mayr, M., Amberger, A., Niederwieser, D., Gupta, R. S., Mizzen, L., Xu, Q. and Wick, G. 1997. Macrophagelysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis 128:27.
19. Xu, Q. and Wick, G. 1996. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol. Med. Today 2:372.
20. Xu, Q., Willeit, J., Marosi, M., Kleindienst, R., Oberhollenzer, F., Kiechl, S., Stulnig, T., Luef, G. and Wick, G. 1993. Association of serum antibodies to heat-shock protein 65 with carotid athersclerosis. Lancet 341:255
21. Latif, N., Yacoub, M. H. and Dunn, M. J. 1997. Association of pretransplant anti-heart antibodies against human heat-shock protein 60 with clinical course following cardiac transplantation. Transplant. Proc. 29:1039
22. Handley, H. H., Yu, J., Yu, D. T. Y., Singh, B., Gupta, R. S. and Vaughan, J. H. 1996. Autoantibodies to human heat shock protein (hsp)60 may be induced by Escherichia coli GroEL. Clin. Exp. Immunol. 103:429.
23. Elias, D., Markovits, D., Reshef, T., van der Zee, R. and Cohen, I. R. 1990. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat chock protein. Proc. Natl Acad. Sci. USA 87:1576.
24. Danieli, M. G., Candela, M., Richiatti, A. M., Reginelli, R., Daniell, G., Cohen, I. R. and Gabrielli, A. 1992. Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma) J. Autoimmun. 5:443.
25. de Graeff-Meeder, E. R., Rijkers, G. T., Voorhorst-Ogink, M. M., Kuis, W., van der Zee, R., van Eden, W. and Zegers, B. J. 1994. Antibodies to human hsp60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr. Res. 152:3656
26. Metzler, B., Schett, G., Kleindienst, R., van der Zee, R., Ottenhoff, T., Hajeer, A., Bernstein, R., Xu, Q. and Wick, G. 1997. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:536.